Author pages are created from data sourced from our academic publisher partnerships and public sources.
Share This Author
Long‐term Survival of Medically Treated Patients in the Coronary Artery Surgery Study (CASS) Registry
High myocardial jeopardy, high anginal class, and two or three proximal diseased vessels characterize the profile of patients most likely to have received surgical treatment during follow-up. Expand
Three‐Year Outcome After Balloon Aortic Valvuloplast: Insights Into Prognosis of Valvular Aortic Stenosis
Long-term survival after balloon aortic valvuloplasty is poor with 1- and 3-year survival rates of 55% and 23%, respectively, although survivors report fewer symptoms, early restenosis and recurrent hospitalization are common. Expand
A randomized active-controlled trial of mycophenolate mofetil in heart transplant recipients. Mycophenolate Mofetil Investigators.
Substitution of MMF for azathioprine may reduce mortality and rejection in the first year after cardiac transplantation. Expand
Accelerated coronary vascular disease in the heart transplant patient: coronary arteriographic findings.
- S. Gao, E. Alderman, J. Schroeder, J. Silverman, S. Hunt
- Journal of the American College of Cardiology
- 1 August 1988
Cor coronary artery disease in transplant patients represents a mixture of typical atheromatous lesions and unique transplant-related progressive distal obliterative disease that occurs without collateral vessel development. Expand
Effects of intensive multiple risk factor reduction on coronary atherosclerosis and clinical cardiac events in men and women with coronary artery disease. The Stanford Coronary Risk Intervention…
Intensive multifactor risk reduction conducted over 4 years favorably altered the rate of luminal narrowing in coronary arteries of men and women with coronary artery disease and decreased hospitalizations for clinical cardiac events. Expand
Three-year results of a randomized, double-blind, controlled trial of mycophenolate mofetil versus azathioprine in cardiac transplant recipients.
- H. Eisen, J. Kobashigawa, +14 authors Jay A. Johnson
- The Journal of heart and lung transplantation…
- 1 May 2005
MMF reduces mortality and graft loss up to 36 months after transplantation and in patients undergoing intravascular ultrasound, the change in mean maximal intimal thickness was less for the MMF group than for the AZA group. Expand
Prognostic value of angiographic indices of coronary artery disease from the Coronary Artery Surgery Study (CASS).
- I. Ringqvist, L. Fisher, +11 authors D. Fray
- The Journal of clinical investigation
- 1 June 1983
The analysis shows that good prediction from angiographic data results from a combination of left ventricular function and arteriographic extent of disease, and prognostic value for survival without early elective surgery varies between 93 and 16% depending upon the values of these three indices. Expand
Results of coronary artery surgery in patients with poor left ventricular function (CASS).
It is concluded that patients with predominantly ischemic pain symptoms, despite poor left ventricular function, benefit from surgery; however, operative mortality in this high-risk subset must equal or better the 6.9% obtained in this study. Expand
Ten-year follow-up of survival and myocardial infarction in the randomized Coronary Artery Surgery Study.
10-year follow-up results confirm earlier reports that patients with left ventricular dysfunction exhibit long-term benefit from an initial strategy of surgical treatment, and have survival equivalent to those patients randomized to initial surgery. Expand
Effect of Completeness of Revascularization on Long‐term Outcome of Patients With Three‐Vessel Disease Undergoing Coronary Artery Bypass Surgery: A Report From the Coronary Artery Surgery Study…
Complete revascularization (grafts to three or more vessels) in patients with three-vessel coronary disease appears to most benefit those with severe angina and left ventricular dysfunction. Expand